Cargando…
Leptin and risk factors for atherosclerosis: A review
Leptin is a hormone secreted primarily by adipose tissue. It regulates an organism’s metabolism, energy balance, and body weight through a negative feedback mechanism. When a person or animal has low body fat and little energy, the leptin level in the body decreases, and conversely, when there is an...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659641/ https://www.ncbi.nlm.nih.gov/pubmed/37986371 http://dx.doi.org/10.1097/MD.0000000000036076 |
_version_ | 1785148354586476544 |
---|---|
author | Wang, Cheng Chang, Liping Wang, Jia Xia, Libo Cao, Liyuan Wang, Wei Xu, Jianwen Gao, Huize |
author_facet | Wang, Cheng Chang, Liping Wang, Jia Xia, Libo Cao, Liyuan Wang, Wei Xu, Jianwen Gao, Huize |
author_sort | Wang, Cheng |
collection | PubMed |
description | Leptin is a hormone secreted primarily by adipose tissue. It regulates an organism’s metabolism, energy balance, and body weight through a negative feedback mechanism. When a person or animal has low body fat and little energy, the leptin level in the body decreases, and conversely, when there is an excess of nutrients, the leptin level increases, giving a feeling of satiety. However, when leptin levels are abnormal (too high or too low) for a number of reasons, it can negatively affect your health, inducing inflammatory responses, obesity, and other problems. Many studies have shown that abnormal leptin levels, such as hyperleptinemia, are closely associated with common risk factors for atherosclerosis (AS). This review systematically states the relationship between leptin and common risk factors for AS (inflammation, obesity, diabetes mellitus, hypertension, and sleep disorders) and provides some new thoughts on the future direction of research on both. Because the abnormal level of leptin will have adverse effects on multiple atherosclerotic risk factors, how to regulate the leptin level of patients with AS, and whether we can treat and prevent AS by intervening the leptin level, these may be our new research directions in the future. |
format | Online Article Text |
id | pubmed-10659641 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-106596412023-11-17 Leptin and risk factors for atherosclerosis: A review Wang, Cheng Chang, Liping Wang, Jia Xia, Libo Cao, Liyuan Wang, Wei Xu, Jianwen Gao, Huize Medicine (Baltimore) 3400 Leptin is a hormone secreted primarily by adipose tissue. It regulates an organism’s metabolism, energy balance, and body weight through a negative feedback mechanism. When a person or animal has low body fat and little energy, the leptin level in the body decreases, and conversely, when there is an excess of nutrients, the leptin level increases, giving a feeling of satiety. However, when leptin levels are abnormal (too high or too low) for a number of reasons, it can negatively affect your health, inducing inflammatory responses, obesity, and other problems. Many studies have shown that abnormal leptin levels, such as hyperleptinemia, are closely associated with common risk factors for atherosclerosis (AS). This review systematically states the relationship between leptin and common risk factors for AS (inflammation, obesity, diabetes mellitus, hypertension, and sleep disorders) and provides some new thoughts on the future direction of research on both. Because the abnormal level of leptin will have adverse effects on multiple atherosclerotic risk factors, how to regulate the leptin level of patients with AS, and whether we can treat and prevent AS by intervening the leptin level, these may be our new research directions in the future. Lippincott Williams & Wilkins 2023-11-17 /pmc/articles/PMC10659641/ /pubmed/37986371 http://dx.doi.org/10.1097/MD.0000000000036076 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | 3400 Wang, Cheng Chang, Liping Wang, Jia Xia, Libo Cao, Liyuan Wang, Wei Xu, Jianwen Gao, Huize Leptin and risk factors for atherosclerosis: A review |
title | Leptin and risk factors for atherosclerosis: A review |
title_full | Leptin and risk factors for atherosclerosis: A review |
title_fullStr | Leptin and risk factors for atherosclerosis: A review |
title_full_unstemmed | Leptin and risk factors for atherosclerosis: A review |
title_short | Leptin and risk factors for atherosclerosis: A review |
title_sort | leptin and risk factors for atherosclerosis: a review |
topic | 3400 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659641/ https://www.ncbi.nlm.nih.gov/pubmed/37986371 http://dx.doi.org/10.1097/MD.0000000000036076 |
work_keys_str_mv | AT wangcheng leptinandriskfactorsforatherosclerosisareview AT changliping leptinandriskfactorsforatherosclerosisareview AT wangjia leptinandriskfactorsforatherosclerosisareview AT xialibo leptinandriskfactorsforatherosclerosisareview AT caoliyuan leptinandriskfactorsforatherosclerosisareview AT wangwei leptinandriskfactorsforatherosclerosisareview AT xujianwen leptinandriskfactorsforatherosclerosisareview AT gaohuize leptinandriskfactorsforatherosclerosisareview |